Optimi Health Corp. (OPTH)

PriceLoading quote

Financial charts

Revenue

Net income

No reported data

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$426,301$389,850
Research & development$347,698$387,591

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.